drug · Product Intelligence

Quetiapine
Pipeline Intelligence

Quetiapine: 7 indexed trials, 7 sponsors; 0 linked Orange Book patents and 5 FDA-linked events where matched.

⚗
7Indexed trials
▦
7Sponsors
⌁
0Orange Book patent links
◎
5FDA-linked events

Development evidence

NCT00044655Icahn School of Medicine at Mount Sinai · schizophreniaPHASE4
NCT00222495University of Minnesota · schizophreniaNA
NCT00771134H. Lundbeck A/S · depressionPHASE2
NCT01224067Cambridge Health Alliance · anxietyPHASE4
NCT02462473Janssen Research & Development, LLC · schizophreniaPHASE2
NCT04164758ACADIA Pharmaceuticals Inc. · parkinsonsPHASE2
NCT04373317VA Office of Research and Development · parkinsonsPHASE4

FDA / patent evidence

Orange Book match found; no listed patent relation was retained for this product match.

Regulatory context

FDA_APPROVALQUETIAPINE FUMARATE · 2018-11-16
FDA_APPROVALQUETIAPINE FUMARATE · 2017-11-29
FDA_APPROVALQUETIAPINE FUMARATE · 2017-05-09
FDA_APPROVALQUETIAPINE FUMARATE · 2012-03-27
FDA_APPROVALQUETIAPINE FUMARATE · 2012-03-27

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.